首页> 外文期刊>Pediatric Hematology Oncology Journal >Diagnostic yield and accuracy of image-guided percutaneous core needle biopsy of paediatric solid tumours: An experience from Italy
【24h】

Diagnostic yield and accuracy of image-guided percutaneous core needle biopsy of paediatric solid tumours: An experience from Italy

机译:小儿实体瘤的经皮核心针活检的诊断产量和准确性:意大利的经验

获取原文
获取外文期刊封面目录资料

摘要

BackgroundPercutaneous core needle biopsy (PCNB) has become an accepted method to collect tumour tissue samples given its safety, minimal invasiveness, high accuracy and cost-effectiveness.ProcedureIt is a single centre, retrospective evaluation of 213 ultrasound (US) or computed tomography (CT) guided PCNBs of paediatric solid tumours performed from 2005 to 2017. Safety, diagnostic yield, accuracy, and efficacy assessments of the PCNB procedure were performed. Univariate logistic models were applied to assess the relation of the diagnostic yield with patient, procedure and lesion features.ResultsThe image-guide was US in 91.08% of biopsies; the needle gauge was ≥16?G in 69.01% of the biopsies. The anatomical site of lesion was deep in 113 biopsies (53.05%). The nature of the lesion was the only factor associated with diagnostic yield (OR: 4.04; 95% CI 1.23–13.28; p: 0.022), with benign lesion as an unfavourable factor. Complication incidence was 1.41%. Overall, the diagnostic yield of PCNB was 93.90% (95% CI: 89.79-96.71%), the diagnostic accuracy was 96.86% (95% CI: 93.29–98.84%) and the diagnostic efficacy was 93.33% (95% CI: 86.75–97.28%). Sensitivity was 97.94% (95% CI: 92.75–99.75%) and specificity 100% (95% CI: 66.37–100%).ConclusionPCNB can be recommended as the first-choice method for solid tumours diagnosis in paediatric, adolescent and young adult patients because of its high diagnostic success, safety and accessibility.
机译:背景体芯针活检(PCNB)已成为收集肿瘤组织样本的接受方法,鉴于其安全性,最小的侵入性,高精度和成本效益.Procedureit是单一中心,回顾性评估213超声(美国)或计算机断层扫描(CT )引导的小儿实体肿瘤的PCNBS从2005年到2017年进行。进行的PCNB程序的安全性,诊断产量,准确性和功效评估。应用单变量后勤模型评估患者,程序和病变特征的诊断产量的关系。验收的图像指导是我们91.08%的活组织检查;针仪在69.01%的活组织检查中≥16μg。病变的解剖部位在113个活组织检查(53.05%)中深。病变的性质是与诊断产量相关的唯一因素(或:4.04; 95%CI 1.23-13.28; P:0.022),具有良性病变作为不利因素。并发症发病率为1.41%。总体而言,PCNB的诊断产量为93.90%(95%CI:89.79-96.71%),诊断准确率为96.86%(95%CI:93.29-98.84%)和诊断疗效为93.33%(95%CI:86.75 -97.28%)。敏感性为97.94%(95%CI:92.75-99.75%)和特异性100%(95%CI:66.37-100%)。结案可以推荐作为儿科,青少年和年轻成人的实体肿瘤诊断的第一选择方法患者由于其高诊断成功,安全性和可访问性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号